These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1772468)

  • 1. Regression of atherosclerosis in humans by lowering serum cholesterol.
    Yamamoto A
    Atherosclerosis; 1991 Jul; 89(1):1-10. PubMed ID: 1772468
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol-lowering and coronary atherosclerosis: good news and bad news.
    Kreisberg RA
    Am J Med; 1996 Nov; 101(5):455-8. PubMed ID: 8948266
    [No Abstract]   [Full Text] [Related]  

  • 3. [A 15-year follow-up of regression of atherosclerotic plaque of the coronary artery after partial ileal bypass].
    Sedletskiĭ IuI; Lebedev LV; Mirchuk KK; Azovtsev RA
    Vestn Khir Im I I Grek; 1999; 158(5):72-3. PubMed ID: 10645591
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of pravastatin (10 mg/day) on progression of coronary atherosclerosis in patients with serum total cholesterol levels from 160 to 220 mg/dl and angiographically documented coronary artery disease. Coronary Artery Regression Study (CARS) Group.
    Tamura A; Mikuriya Y; Nasu M
    Am J Cardiol; 1997 Apr; 79(7):893-6. PubMed ID: 9104901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing progression of coronary atherosclerosis: beyond cholesterol lowering.
    Waters D
    Can J Cardiol; 1991 Sep; 7(7):VIII-IX. PubMed ID: 1933632
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (REGRESS) Study Group.
    Cobbaert C; Jukema JW; Zwinderman AH; Withagen AJ; Lindemans J; Bruschke AV
    J Am Coll Cardiol; 1997 Nov; 30(6):1491-9. PubMed ID: 9362407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regression of coronary atherosclerosis evaluated by angiography. A review of principal trials and critical study].
    Castaigne A; Albo C; Pham I; Saal JP; Verschuren P
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():31-7. PubMed ID: 8215778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipids and serum apoproteins in subjects with slight or mild coronary atherosclerosis evaluated with angiography].
    Magnavacchi P; Boiardi L; Barbagallo M; Novo S; Bertolotti M; Benassi A; Butturini L; Biagi R; Pedrazzini F; Barbagallo CM
    Cardiologia; 1992 May; 37(5):351-5. PubMed ID: 1423368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
    Post Coronary Artery Bypass Graft Trial Investigators
    N Engl J Med; 1997 Jan; 336(3):153-62. PubMed ID: 8992351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.
    Cashin-Hemphill L; Mack WJ; Pogoda JM; Sanmarco ME; Azen SP; Blankenhorn DH
    JAMA; 1990 Dec; 264(23):3013-7. PubMed ID: 2243429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography.
    Mack WJ; LaBree L; Liu C; Selzer RH; Hodis HN
    Atherosclerosis; 2000 Jun; 150(2):371-9. PubMed ID: 10856529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid lowering after percutaneous coronary intervention. Intended and achieved treatment goals in real life].
    Germing A; Lindstaedt M; Mügge A
    Med Klin (Munich); 2005 Dec; 100(12):781-4. PubMed ID: 16453092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholesterol lowering and life expectancy: a critical evaluation].
    Klepzig H; Kaltenbach M
    Z Kardiol; 1992 Jul; 81(7):347-53. PubMed ID: 1509792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression and stabilization of coronary artery lesions. Angiographic trials move beyond the NCEP treatment guidelines.
    DeBoer LW; Vailas LI
    Nebr Med J; 1992 Jun; 77(6):124-9. PubMed ID: 1620266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Band neutrophil count and the presence and severity of coronary atherosclerosis.
    Kawaguchi H; Mori T; Kawano T; Kono S; Sasaki J; Arakawa K
    Am Heart J; 1996 Jul; 132(1 Pt 1):9-12. PubMed ID: 8701881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT).
    Burton JR; Teo KK; Buller CE; Plante S; Catellier D; Tymchak W; Taylor D; Dzavik V; Montague TJ;
    Can J Cardiol; 2003 Apr; 19(5):487-91. PubMed ID: 12717482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators.
    Tatami R; Inoue N; Itoh H; Kishino B; Koga N; Nakashima Y; Nishide T; Okamura K; Saito Y; Teramoto T
    Atherosclerosis; 1992 Jul; 95(1):1-13. PubMed ID: 1642687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy.
    Waters D; Higginson L; Gladstone P; Boccuzzi SJ; Cook T; Lespérance J
    Circulation; 1995 Nov; 92(9):2404-10. PubMed ID: 7586338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.